Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 33 (1), 409-21

Conserved Transcription Factor Binding Sites of Cancer Markers Derived From Primary Lung Adenocarcinoma Microarrays


Conserved Transcription Factor Binding Sites of Cancer Markers Derived From Primary Lung Adenocarcinoma Microarrays

Yee Leng Yap et al. Nucleic Acids Res.

Erratum in

  • Nucleic Acids Res. 2005;33(8):2764. Lam, David CL [added]; Girard, L [added]; Wang, Elaine [added]; Chiu, SW [added]; Chung, Lap Ping [added]; Lam, WK [added]; Minna, John D [added]


Gene transcription in a set of 49 human primary lung adenocarcinomas and 9 normal lung tissue samples was examined using Affymetrix GeneChip technology. A total of 3442 genes, called the set M AD, were found to be either up- or down-regulated by at least 2-fold between the two phenotypes. Genes assigned to a particular gene ontology term were found, in many cases, to be significantly unevenly distributed between the genes in and outside M AD. Terms that were overrepresented in M AD included functions directly implicated in the cancer cell metabolism. Based on their functional roles and expression profiles, genes in M AD were grouped into likely co-regulated gene sets. Highly conserved sequences in the 5 kb region upstream of the genes in these sets were identified with the motif discovery tool, MoDEL. Potential oncogenic transcription factors and their corresponding binding sites were identified in these conserved regions using the TRANSFAC 8.3 database. Several of the transcription factors identified in this study have been shown elsewhere to be involved in oncogenic processes. This study searched beyond phenotypic gene expression profiles in cancer cells, in order to identify the more important regulatory transcription factors that caused these aberrations in gene expression.


Figure 1
Figure 1
Histogram of the cancer associated genes (MAD) correlation to the tissue labels (normal or lung adenocarcinomas). The average histograms generated from 10 separate random permutations of the cancer labels in the original lung adenocarcinoma dataset is also displayed.

Similar articles

See all similar articles

Cited by 17 PubMed Central articles

See all "Cited by" articles


    1. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 2000;100:57–70. - PubMed
    1. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer statistics, 2003. CA Cancer J. Clin. 2003;53:5–26. - PubMed
    1. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., Smith H.O., Yandell M., Evans C.A., Holt R.A., et al. The sequence of the human genome. Science. 2001;291:1304–1351. - PubMed
    1. Ramaswamy S., Golub T.R. DNA microarrays in clinical oncology. J. Clin. Oncol. 2002;20:1932–1941. - PubMed
    1. Geller S.C., Gregg J.P., Hagerman P., Rocke D.M. Transformation and normalization of oligonucleotide microarray data. Bioinformatics. 2003;19:1817–1823. - PubMed

Publication types